Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary melioidosis

M Ip1, L G Osterberg, P Y Chau

  • 1Division of Pulmonary and Critical Care Medicine, Stanford (Calif) University Medical Center, USA.

Chest
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Across time and space: phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii in a network of general and convalescent hospitals.

The Journal of hospital infection·2025
Same author

Skin microbial signatures for eczema: a birth cohort study (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Limb presentations of invasive Group A Streptococci infection in children.

JPRAS open·2024
Same author

Faecal microbiota transplantation for patients with irritable bowel syndrome: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Risk of hospitalised bronchiectasis exacerbation based on blood eosinophil counts.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Carriage prevalence of antimicrobial resistance in Hong Kong: a longitudinal study (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2022
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
See all related articles

Melioidosis, a tropical disease caused by Pseudomonas pseudomallei, affects the lungs and is difficult to treat. Increased global travel necessitates clinician awareness of this infection, which can mimic tuberculosis.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Melioidosis is caused by the bacterium Pseudomonas pseudomallei.
  • It is prevalent in tropical regions like Southeast Asia and Australia but is increasingly reported globally.
  • The lungs are the most commonly affected organ, presenting as pneumonia or cavitary disease.

Purpose of the Study:

  • To review the epidemiology, clinical presentations, diagnosis, and treatment of pulmonary melioidosis.
  • To raise awareness among clinicians regarding melioidosis, especially in non-endemic areas.
  • To highlight the challenges in treating melioidosis due to its resistance and high relapse rates.

Main Methods:

  • Review of existing literature on pulmonary melioidosis.
  • Analysis of clinical presentations, including acute pneumonia and indolent cavitary disease.

Related Experiment Videos

  • Discussion of diagnostic approaches and treatment strategies, considering antibiotic resistance.

    • Main Results:

    • Pulmonary melioidosis can manifest acutely or indolently, often resembling tuberculosis in non-endemic regions.
    • Pseudomonas pseudomallei is resistant to aminoglycosides, complicating treatment.
    • High mortality and relapse rates are associated with melioidosis, particularly in endemic areas.

    Conclusions:

    • Clinicians must be aware of melioidosis, especially with increasing global mobility.
    • Early diagnosis and appropriate treatment are crucial due to the challenges in managing this infection.
    • Further research into effective treatment strategies is needed to combat recalcitrance and high relapse rates.